Superoxide dismutase activity as a predictor of adverse outcomes in patients with nonischemic dilated cardiomyopathy
Related Experiment Video
Updated: Jan 25, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Ewa Romuk1, Wojciech Jacheć2, Ewa Kozielska-Nowalany2
1Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, Jordana 19 Street, 41-808, Zabrze, Poland. eromuk@gmail.com.
Insights
Elevated superoxide dismutase (SOD) activity in patients with nonischemic dilated cardiomyopathy indicates a poorer prognosis. This finding suggests serum SOD levels can help predict adverse outcomes in heart failure (HF).
Area of Science:
- Biochemistry
- Cardiology
- Biomarkers
Background:
- Oxidative stress is a key factor in heart failure (HF) progression.
- Superoxide dismutase (SOD) and its isoenzymes (CuZnSOD, MnSOD) play crucial roles in managing oxidative stress.
- Identifying reliable prognostic factors in nonischemic dilated cardiomyopathy (NIDCM) is essential for patient management.
Purpose of the Study:
- To evaluate the efficacy of total SOD, CuZnSOD, and MnSOD activities as prognostic factors in NIDCM.
- To assess the predictive value of SOD isoenzyme activities for long-term clinical outcomes in NIDCM patients.
- To determine if serum SOD activity can serve as a predictor of adverse outcomes in HF.
Main Methods:
- A 5-year follow-up study involving 109 patients with NIDCM.
- Measurement of total SOD, MnSOD, and CuZnSOD activities.
- Analysis of clinical, echocardiographic, and laboratory parameters, including NT-proBNP, hemoglobin, sodium, creatinine clearance, left ventricular ejection fraction (LVEF), BMI, and NYHA class.
- Regression analysis to identify predictors of long-term clinical outcomes (death, heart transplant, combined endpoint).
Main Results:
- Total serum SOD activity was a significant predictor of worse long-term clinical outcomes, independent of NT-proBNP, hemoglobin, sodium, creatinine clearance, LVEF, BMI, and NYHA class.
- MnSOD and CuZnSOD activities also predicted worse outcomes, though statistical significance was borderline after adjustment for LVEF.
- Increased activities of total SOD and its isoenzymes in NIDCM patients correlated with poor prognosis.
Conclusions:
- Elevated serum SOD activity and its isoenzymes (MnSOD, CuZnSOD) in NIDCM patients are associated with a poor prognosis.
- Serum SOD activity may serve as a valuable and independent predictor of adverse clinical outcomes in patients with heart failure.
- These findings highlight the prognostic utility of assessing oxidative stress markers in NIDCM.
Abstract:
Oxidative stress contributes to progression of heart failure (HF). The present study analyzed the efficacy of the activities of superoxide dismutase (SOD) and its isoenzymes (CuZnSOD and MnSOD) as prognostic factors in dilated cardiomyopathy. The usefulness of activities of total SOD, MnSOD, and CuZnSOD was assessed, taking into account clinical, echocardiographic, and laboratory parameters as risk predictors of long-term clinical outcomes (death, heart transplant, combined end point) in 109 patients with nonischemic dilated cardiomyopathy (NIDCM) in this study with a 5-year follow-up. Regression analysis showed that total serum SOD activity was a predictor of worse long-term clinical outcome even after adjustment for NT-proBNP, hemoglobin, sodium, creatinine clearance, left ventricular ejection fraction (LVEF), BMI, and NYHA class (LVEF: HR 1.059, 95% CI 1.007-1.114, P = 0.026; BMI: HR 1.073, 95% CI 1.021-1.126, P = 0.005; NYHA: HR 1.073, 95% CI 1.022-1.126, P = 0.005). MnSOD and CuZnSOD activities were also predictors of worse long-term clinical outcome even after adjustment for laboratory parameters and BMI or NYHA class; however, after adjustment for LVEF, a borderline statistical significance was achieved (LVEF: HR 1.054, 95% CI 0.993-1.119, P = 0.081 [MnSOD]; HR 1.092, 95% CI 0.989-1.297, P = 0.082 [CuZnSOD]). Increased activities of total serum SOD and its isoenzymes in NIDCM patients correspond with a poor prognosis and may have prognostic value in the prediction of long-term clinical outcomes. In conclusion, the present study shows that serum SOD activity may be a useful predictor of adverse outcome in HF.
More Related Videos
08:57Simultaneous Measurement of Superoxide/Hydrogen Peroxide and NADH Production by Flavin-containing Mitochondrial Dehydrogenases
Published on: February 24, 2018
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Predicting Reaction Outcomes
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...